Company news
Antibiotice SA news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Schimbare in conducerea societatii
October 30, 2026
Hotarari AGA O 29.10.2026
October 29, 2026
Disponibilitate raport privind indicatorii cheie de performanta Trim. III 2026
October 22, 2026
Plata dividend 2025
October 5, 2026
Hotarari AGA O 30.09.2026
September 30, 2026
Convocare AGAO 29/30.10.2026
September 16, 2026
Propunere dividend 2025
August 18, 2026
Convocare AGAO 30.09.2026
August 18, 2026
Raport semestrial S1 2026
August 17, 2026
Teleconferinta Rezultate Financiare Sem. I 2026
August 10, 2026
Disponibilitate raport privind indicatorii cheie de performanta Trim II 2026
July 21, 2026
Antibiotice strengthens its international growth: sales advance in the US and entry into a new market in Europe
June 5, 2026
Antibiotice: SA is accelerating its strategic investments through a 67 million euro financing facility granted by Banca Transilvania
May 21, 2026
Romanian pharmaceutical producer Antibiotice to benefit from EIB guidance on strengthening corporate governance and investment capacity
May 13, 2026
Antibiotice: Directors' Report 2025
March 27, 2026
Antibiotice: Critical medicines and biosimilars – the priority of new investment projects at Antibiotice SA
March 6, 2026
Iași – Investments worth 75 million euros for the development of a research, development and production center for critical medicines, through the STEP program
November 12, 2025
Nokia expands defense portfolio with two advanced tactical communication solutions
September 9, 2025
Notice of availability H1 2025 Report2025-08-14
August 14, 2025
Antibiotice: SA announces the finalization of the selection and designation of the management bodies2025-06-20
June 20, 2025
Antibiotice: Iași Strengthens Its Partnership with the UK Public Healthcare System through a New Tender Win
June 6, 2025
Current Report – Auctiont UK2025-06-05
June 5, 2025
Antibiotice: Iași Launches 3 Innovative Products at the National Conference on Practical Phytotherapy and Nutraceuticals
May 12, 2025
Current Report GSM O & E request – Infinity Capital Investments SA2025 04 22
April 23, 2025
Availability for the Annual Report 2024 – PRELIMINARY RESULTS2025 02 26
February 26, 2025
2023 Dividend payment2024 09 23
September 23, 2024
Antibiotice: Increasing results in accordance with the business plan “The Future Together” for Antibiotice Iași, in the first semester of 2024
August 14, 2024
Antibiotice: Iasi invests in digitalization2024-04-25
April 25, 2024
Antibiotice: Iasi invests in digitalization for the transition to a sustainable business
April 25, 2024
The Antibiotice Iași business growth by 24% in 2023 strengthens the company’s development
April 19, 2024
Antibiotice: Iasi has commissioned a 2.5 MW photovoltaic plant, financed by the RRRP, which will provide over 25% of the electricity requirements
March 28, 2024
Commissioning of the 2.5 MW Photovoltaic Power Plant2024-03-28
March 28, 2024
Antibiotice: Iasi maintains the growth trend of turnover and profitability in the first 9 months of 2023
November 15, 2023
Decks
The 5 newest of 9 decks. Every deck is listed under its year.
- Investor Presentation (February 2026)
Investor deck · 13 slides · February 2026
- H1 2025 Earnings Presentation
Earnings · 15 slides · Aug 21, 2025
- Investor Presentation (September 2023)
Investor deck · 16 slides · September 2023
- H1 2022 Earnings Presentation
Earnings · 15 slides · October 2022
- Investor Presentation (November 2021)
Investor deck · 23 slides · November 2021